Atria Investments’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.82M | Buy |
53,709
+5,867
| +12% | +$310K | 0.03% | 601 |
|
|
2026
Q1 | $2.64M | Sell |
47,842
-38,452
| -45% | -$2.08M | 0.03% | 587 |
|
|
2025
Q4 | $4.23M | Sell |
86,294
-13,560
| -14% | -$632K | 0.05% | 439 |
|
|
2025
Q3 | $4.31M | Sell |
99,854
-7,655
| -7% | -$299K | 0.05% | 439 |
|
|
2025
Q2 | $4.13M | Buy |
107,509
+67,104
| +166% | +$2.56M | 0.05% | 438 |
|
|
2025
Q1 | $1.57M | Buy |
40,405
+3,339
| +9% | +$122K | 0.02% | 807 |
|
|
2024
Q4 | $1.25M | Sell |
37,066
-3,042
| -8% | -$110K | 0.02% | 872 |
|
|
2024
Q3 | $1.64M | Sell |
40,108
-8,663
| -18% | -$354K | 0.02% | 740 |
|
|
2024
Q2 | $1.88M | Sell |
48,771
-5,886
| -11% | -$248K | 0.02% | 669 |
|
|
2024
Q1 | $2.34M | Buy |
54,657
+11,804
| +28% | +$487K | 0.03% | 592 |
|
|
2023
Q4 | $1.59M | Buy |
42,853
+8,135
| +23% | +$292K | 0.02% | 688 |
|
|
2023
Q3 | $1.26M | Buy |
34,718
+6,447
| +23% | +$229K | 0.02% | 752 |
|
|
2023
Q2 | $1.01M | Buy |
+28,271
| New | +$1.01M | 0.02% | 823 |
|
|
2022
Q3 | – | Sell |
-19,534
| Closed | -$1.06M | – | 764 |
|
|
2022
Q2 | $1.06M | Sell |
19,534
-8,015
| -29% | -$442K | 0.02% | 728 |
|
|
2022
Q1 | $1.5M | Buy |
27,549
+4,568
| +20% | +$248K | 0.03% | 673 |
|
|
2021
Q4 | $1.27M | Buy |
+22,981
| New | +$1.2M | 0.02% | 737 |
|
|
2020
Q4 | – | Sell |
-27,741
| Closed | -$1.3M | – | 676 |
|
|
2020
Q3 | $1.3M | Sell |
27,741
-5,881
| -17% | -$295K | 0.04% | 474 |
|
|
2020
Q2 | $1.71M | Buy |
33,622
+6,802
| +25% | +$349K | 0.06% | 357 |
|
|
2020
Q1 | $1.27M | Sell |
26,820
-4,907
| -15% | -$262K | 0.1% | 196 |
|
|
2019
Q4 | $1.86M | Buy |
+31,727
| New | +$1.76M | 0.05% | 330 |
|
|
2019
Q2 | – | Sell |
-4,174
| Closed | -$218K | – | 1013 |
|
|
2019
Q1 | $218K | Sell |
4,174
-1,854
| -31% | -$92.6K | 0.01% | 829 |
|
|
2018
Q4 | $288K | Sell |
6,028
-3,398
| -36% | -$167K | 0.01% | 662 |
|
|
2018
Q3 | $473K | Buy |
9,426
+775
| +9% | +$39.4K | 0.02% | 606 |
|
|
2018
Q2 | $436K | Sell |
8,651
-5,043
| -37% | -$254K | 0.02% | 610 |
|
|
2018
Q1 | $669K | Buy |
13,694
+3,430
| +33% | +$160K | 0.03% | 441 |
|
|
2017
Q4 | $455K | Buy |
10,264
+1,499
| +17% | +$69.2K | 0.02% | 503 |
|
|
2017
Q3 | $445K | Buy |
8,765
+1,231
| +16% | +$62.5K | 0.02% | 482 |
|
|
2017
Q2 | $406K | Sell |
7,534
-5,684
| -43% | -$303K | 0.02% | 480 |
|
|
2017
Q1 | $697K | Buy |
13,218
+232
| +2% | +$11.8K | 0.05% | 325 |
|
|
2016
Q4 | $625K | Buy |
12,986
+2,736
| +27% | +$135K | 0.05% | 300 |
|
|
2016
Q3 | $553K | Sell |
10,250
-933
| -8% | -$51.2K | 0.05% | 293 |
|
|
2016
Q2 | $604K | Buy |
+11,183
| New | +$589K | 0.07% | 230 |
|
|
2014
Q3 | – | Sell |
-20,178
| Closed | -$1.35M | – | 466 |
|
|
2014
Q2 | $1.35M | Buy |
+20,178
| New | +$1.37M | 0.13% | 139 |
|
Other funds holding GSK
JEST
Atria Investments's GSK Position: Q2 2026 in Review
Atria Investments increased its GSK (GSK) stake by 12% in Q2 2026, buying an estimated $310K and bringing the position to 53,709 shares worth $2.82M. The position accounts for 0.03% of the portfolio, ranked #601.
Atria Investments first reported a position in GSK in Q2 2014 and has held it in 33 quarters since. The position peaked at $4.31M in Q3 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Atria Investments held 53,709 shares of GSK worth $2.82M as of Q2 2026.
- Atria Investments bought 5,867 GSK shares in Q2 2026, an estimated $310K.
- GSK made up 0.03% of Atria Investments's portfolio in Q2 2026, its #601 holding.
- Atria Investments first reported a position in GSK in Q2 2014 and has held it in 33 quarters since.
- Atria Investments's GSK position peaked at $4.31M in Q3 2025.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.